Advertisement
Screener

INNOVIVA, INC. (INVA) Other Noncash Income (Expense)

2.9 / 5 stars · 69/119 Roast Me

INNOVIVA, INC. Other Noncash Income (Expense)

INNOVIVA, INC. (INVA) reported Other Noncash Income (Expense) of -$1.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-05

  • INNOVIVA, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$197.00K, a 152.39% decline year-over-year.
  • INNOVIVA, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$1.03M.
  • INNOVIVA, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$1.50M, a 475.63% decline year-over-year.
  • INNOVIVA, INC. other noncash income (expense) for the quarter ending 2025-09-30 was $21.00K, a 87.72% decline year-over-year.
  • INNOVIVA, INC. other noncash income (expense) for fiscal 2025 was -$1.90M, a 362.74% decline from fiscal 2024.
  • INNOVIVA, INC. other noncash income (expense) for fiscal 2024 was $722.00K, a 39.65% increase from fiscal 2023.
  • INNOVIVA, INC. other noncash income (expense) for fiscal 2023 was $517.00K.
  • INNOVIVA, INC. other noncash income (expense) for fiscal 2022 was -$3.40M, a 1413.51% decline from fiscal 2021.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 9 month as first filedOther Noncash Income (Expense) 12 month
2026-06-30-$197.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$1.22M
10-Q · filed 2026-08-05
-$2.72M
derived: sum of 3 quarters · filed 2026-08-05
-$2.70M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$1.03M
10-Q · filed 2026-05-06
-$2.52M
derived: sum of 2 quarters · filed 2026-05-06
-$2.50M
derived: sum of 3 quarters · filed 2026-05-06
-$2.12M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$1.47M
derived: sum of 2 quarters · filed 2026-02-25
-$1.10M
derived: sum of 3 quarters · filed 2026-08-05
-$1.90M
10-K · filed 2026-02-25
2025-09-30$21.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$397.00K
derived: sum of 2 quarters · filed 2026-08-05
-$402.00K
10-Q · filed 2025-11-05
-$4.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$376.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$423.00K
10-Q · filed 2026-08-05
-$25.00K
derived: sum of 3 quarters · filed 2026-08-05
$146.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$799.00K
10-Q · filed 2026-05-06
-$401.00K
derived: sum of 2 quarters · filed 2026-05-06
-$230.00K
derived: sum of 3 quarters · filed 2026-05-06
-$1.59M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$398.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$569.00K
derived: sum of 2 quarters · filed 2026-02-25
-$791.00K
derived: sum of 3 quarters · filed 2026-02-25
$722.00K
10-K · filed 2026-02-25
2024-09-30$171.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$1.19M
derived: sum of 2 quarters · filed 2025-11-05
$324.00K
10-Q · filed 2025-11-05
$71.00K
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30-$1.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$153.00K
10-Q · filed 2025-08-06
-$100.00K
derived: sum of 3 quarters · filed 2026-02-25
$1.73M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$1.51M
10-Q · filed 2025-05-07
$1.26M
derived: sum of 2 quarters · filed 2026-02-25
$3.09M
derived: sum of 3 quarters · filed 2026-02-25
-$32.00K
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31-$253.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$1.58M
derived: sum of 2 quarters · filed 2026-02-25
-$1.54M
derived: sum of 3 quarters · filed 2026-02-25
$517.00K
10-K · filed 2026-02-25
2023-09-30$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$1.29M
derived: sum of 2 quarters · filed 2024-11-06
$770.00K
10-Q · filed 2024-11-06
-$606.00K
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30-$3.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$1.06M
10-Q · filed 2024-07-31
-$2.44M
derived: sum of 3 quarters · filed 2025-02-26
-$3.61M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$2.06M
10-Q · filed 2024-05-08
$686.00K
derived: sum of 2 quarters · filed 2025-02-26
-$483.00K
derived: sum of 3 quarters · filed 2025-02-26
-$1.06M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31-$1.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$2.54M
derived: sum of 2 quarters · filed 2025-02-26
-$3.12M
derived: sum of 3 quarters · filed 2025-02-26
-$3.40M
10-K · filed 2025-02-26
2022-09-30-$1.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$1.75M
derived: sum of 2 quarters · filed 2023-11-01
-$2.03M
10-Q · filed 2023-11-01
-$995.00K
10-Q · filed 2022-11-09
-$2.02M
derived: sum of 4 quarters · filed 2024-03-05
2022-06-30-$577.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$857.00K
10-Q · filed 2023-08-02
-$849.00K
derived: sum of 3 quarters · filed 2024-03-05
-$582.00K
derived: sum of 4 quarters · filed 2024-03-05
2022-03-31-$280.00K
10-Q · filed 2023-05-09
-$272.00K
derived: sum of 2 quarters · filed 2024-03-05
-$5.00K
derived: sum of 3 quarters · filed 2024-03-05
-$13.00K
derived: sum of 4 quarters · filed 2024-03-05
2021-12-31$8.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05
$275.00K
derived: sum of 2 quarters · filed 2024-03-05
$267.00K
derived: sum of 3 quarters · filed 2024-03-05
$259.00K
10-K/A · filed 2024-03-05
2021-09-30$267.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$259.00K
derived: sum of 2 quarters · filed 2022-11-09
$251.00K
10-Q · filed 2022-11-09
$244.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$8.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27
-$16.00K
10-Q · filed 2022-07-27
-$23.00K
derived: sum of 3 quarters · filed 2023-02-28
-$31.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$8.00K
10-Q · filed 2022-05-05
-$15.00K
derived: sum of 2 quarters · filed 2023-02-28
-$23.00K
derived: sum of 3 quarters · filed 2023-02-28
-$29.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$15.00K
derived: sum of 2 quarters · filed 2023-02-28
-$21.00K
derived: sum of 3 quarters · filed 2023-02-28
-$21.00K
10-K · filed 2023-02-28
2020-09-30-$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
-$14.00K
derived: sum of 2 quarters · filed 2021-10-27
-$14.00K
10-Q · filed 2021-10-27
-$14.00K
derived: sum of 4 quarters · filed 2022-03-17
2020-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
-$6.00K
10-Q · filed 2021-07-29
-$6.00K
derived: sum of 3 quarters · filed 2022-03-17
-$6.00K
derived: sum of 4 quarters · filed 2022-03-17
2020-03-31$0.00
10-Q · filed 2021-04-28
$0.00
derived: sum of 2 quarters · filed 2022-03-17
$0.00
derived: sum of 3 quarters · filed 2022-03-17
2019-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17
$0.00
derived: sum of 2 quarters · filed 2022-03-17
$0.00
10-K/A · filed 2022-03-17
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28
$0.00
10-Q · filed 2020-10-28
2019-06-30$0.00
10-Q · filed 2020-07-29
2018-12-31$0.00
10-K · filed 2021-02-25
2017-12-31$0.00
10-K · filed 2018-02-23
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$0.00
derived: sum of 2 quarters · filed 2018-02-23
$0.00
10-K · filed 2018-02-23
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$0.00
10-Q · filed 2016-11-03
2016-06-30$0.00
10-Q · filed 2016-08-04
2015-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$1.00K
derived: sum of 2 quarters · filed 2018-02-23
$1.00K
derived: sum of 3 quarters · filed 2018-02-23
$3.00K
10-K · filed 2018-02-23
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$0.00
derived: sum of 2 quarters · filed 2016-11-03
$2.00K
10-Q · filed 2016-11-03
$2.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$2.00K
10-Q · filed 2016-08-04
$2.00K
derived: sum of 3 quarters · filed 2017-02-28
$2.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$2.00K
10-Q · filed 2016-05-05
$2.00K
derived: sum of 2 quarters · filed 2017-02-28
$2.00K
derived: sum of 3 quarters · filed 2017-02-28
$2.00K
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$0.00
derived: sum of 2 quarters · filed 2017-02-28
$0.00
derived: sum of 3 quarters · filed 2017-02-28
$2.00K
10-K · filed 2017-02-28
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$0.00
derived: sum of 2 quarters · filed 2015-11-05
$2.00K
10-Q · filed 2015-11-05
$2.00K
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$2.00K
10-Q · filed 2015-08-06
$2.00K
derived: sum of 3 quarters · filed 2016-02-24
-$18.00K
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31$2.00K
10-Q · filed 2015-05-08
$2.00K
derived: sum of 2 quarters · filed 2016-02-24
-$18.00K
derived: sum of 3 quarters · filed 2016-02-24
-$16.00K
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
-$20.00K
derived: sum of 2 quarters · filed 2016-02-24
-$18.00K
derived: sum of 3 quarters · filed 2016-02-24
-$17.00K
10-K · filed 2016-02-24
2013-09-30-$20.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
-$18.00K
derived: sum of 2 quarters · filed 2014-11-04
-$17.00K
10-Q · filed 2014-11-04
2013-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$3.00K
10-Q · filed 2014-08-07
2013-03-31$1.00K
10-Q · filed 2014-05-07
2012-12-31-$187.00K
10-K · filed 2015-02-27
2011-12-31-$18.00K
10-K · filed 2014-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10